Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Financing (TTM): 49.74M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 49.74M |
June 30, 2023 | 49.74M |
March 31, 2023 | 49.67M |
December 31, 2022 | 0.182M |
Date | Value |
---|---|
September 30, 2022 | 164.24M |
June 30, 2022 | 162.76M |
March 31, 2022 | 163.88M |
December 31, 2021 | 263.78M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.182M
Minimum
Dec 2022
263.78M
Maximum
Dec 2021
113.00M
Average
106.25M
Median
Cash from Financing (TTM) Benchmarks
Karuna Therapeutics Inc (DELISTED) | 483.37M |
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 14.71M |
iBio Inc | 14.24M |
Theriva Biologics Inc | 0.68M |